EZC Medical Announces FDA 510(k) Clearance for the IntubaidFlexTM as an Aid in the Placement of Endotracheal Tube

San Francisco, California, August 6 --- EZC Medical, LLC, a technology leader in the development of proprietary, affordable and disposable visualization technology with widespread medical applications announced today that it has received 510(k) clearance for its Intubaid FlexTM, an airway management and visualization device, intended to be used as an aid in the placement of an Endotracheal Tube (ETT) directly or through an Intubating Laryngeal Mask during difficult and non difficult intubation procedures.

The Intubaid FlexTM will achieve its purpose by providing the user with a visual confirmation of where the tip of the device is in the human anatomy. The flexible tip of the device allows the user to guide the ETT in the desired direction. "FDA clearance of our 510(k) is important to physicians and patients alike because it acknowledges the value of the IntubaidFlex in helping physicians, particularly during difficult intubation procedures," said Jerry Sanders, Managing Director & CEO of EZC Medical.

"We are excited about the demonstrated capability of our device and its potential for saving lives," said Dr. Pavan Sethi, Vice President Regulatory, Quality and Scientific Affairs at EZC Medical.

About EZC Medical, LLC EZC medical is focused on cost effective solutions for effective airway management. The company is FDA cleared and CE marked. The "chip-on-stick platform" of the IntubaidFlex is also basis for other products under development by EZC Medical. For more information, visit www.ezcmedical.com.